Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 29.60
-0.05 (-0.17%)
Sep 8, 2026, 1:30 PM CST
Synmosa Biopharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,730 | 1,891 | 1,186 | 918.56 | 1,088 | 868.17 |
Short-Term Investments | 191.63 | 318.15 | 120.31 | 520 | 310 | 115 |
Trading Asset Securities | 858.36 | 721.96 | 575.94 | 211.45 | 20.1 | 5.26 |
Cash & Short-Term Investments | 2,780 | 2,931 | 1,882 | 1,650 | 1,418 | 988.43 |
Cash Growth | -15.42% | 55.73% | 14.08% | 16.38% | 43.43% | 32.61% |
Accounts Receivable | 1,667 | 1,382 | 1,252 | 1,155 | 1,125 | 799.64 |
Other Receivables | 8.15 | 62.32 | 57.88 | 48.43 | 20.86 | 10.47 |
Receivables | 1,675 | 1,444 | 1,310 | 1,203 | 1,146 | 810.11 |
Inventory | 2,425 | 2,247 | 1,787 | 1,651 | 1,384 | 1,214 |
Prepaid Expenses | 159.93 | 43.82 | 34.54 | 28.1 | - | 51.11 |
Other Current Assets | 12.81 | 1.87 | 5.31 | 7 | 60.84 | 35.05 |
Total Current Assets | 7,053 | 6,669 | 5,019 | 4,539 | 4,008 | 3,099 |
Property, Plant & Equipment | 5,903 | 5,425 | 5,589 | 5,557 | 5,638 | 5,662 |
Long-Term Investments | 583.95 | 387.28 | 336.48 | 222.87 | 223.01 | 303.48 |
Goodwill | 84.7 | 50.26 | 62.29 | 62.29 | 71.08 | 7.27 |
Other Intangible Assets | 543.23 | 383.9 | 449.22 | 496.56 | 496.8 | 494.03 |
Long-Term Deferred Tax Assets | 367.57 | 399.47 | 363.27 | 330.56 | 331.78 | 329.28 |
Other Long-Term Assets | 739.55 | 671.08 | 484.54 | 519.9 | 433.53 | 421.53 |
Total Assets | 15,275 | 13,985 | 12,304 | 11,729 | 11,203 | 10,317 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 725.04 | 561.2 | 471.02 | 427.54 | 446.16 | 249.58 |
Accrued Expenses | - | 496.44 | 443.36 | 381.68 | 368.47 | 264.64 |
Short-Term Debt | 1,355 | 686.48 | 674.89 | 661.22 | 584.08 | 763.77 |
Current Portion of Long-Term Debt | 138.3 | 230.4 | 72.33 | 289.39 | 584.42 | 413.9 |
Current Portion of Leases | 28.27 | 25.57 | 22.94 | 23.3 | 16.7 | 6.74 |
Current Income Taxes Payable | 87.59 | 119.75 | 142.57 | 118.29 | 95.54 | 53.18 |
Current Unearned Revenue | 146.88 | 86.41 | 163.72 | 172.29 | 173.43 | 126.87 |
Other Current Liabilities | 990.15 | 56.06 | 83.76 | 44.71 | 53.91 | 10.21 |
Total Current Liabilities | 3,471 | 2,262 | 2,075 | 2,118 | 2,323 | 1,889 |
Long-Term Debt | 1,780 | 1,537 | 1,729 | 1,400 | 2,122 | 2,272 |
Long-Term Leases | 30.12 | 33.67 | 49.86 | 58.66 | 48.42 | 6.76 |
Long-Term Unearned Revenue | 15.14 | 8.84 | 5.53 | 2.35 | - | - |
Pension & Post-Retirement Benefits | 7.25 | 7.48 | 7.8 | 12.24 | 13.89 | 19.18 |
Long-Term Deferred Tax Liabilities | 104.12 | 35.59 | 37.42 | 35.45 | 34.52 | 34.2 |
Other Long-Term Liabilities | 0.64 | 1.06 | 1.26 | 0.53 | 12.62 | 0.89 |
Total Liabilities | 5,409 | 3,886 | 3,905 | 3,628 | 4,554 | 4,221 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5,102 | 5,102 | 4,293 | 4,014 | 3,437 | 3,131 |
Additional Paid-In Capital | 2,557 | 2,627 | 2,082 | 2,195 | 1,425 | 1,426 |
Retained Earnings | 899.22 | 1,279 | 1,096 | 1,092 | 1,005 | 613.43 |
Treasury Stock | -217.14 | -154.04 | -205.68 | -486.96 | -486.96 | -402.62 |
Comprehensive Income & Other | 308.79 | -89.1 | -55.82 | -104.78 | -68.18 | -63.04 |
Total Common Equity | 8,650 | 8,764 | 7,210 | 6,710 | 5,312 | 4,706 |
Minority Interest | 1,217 | 1,335 | 1,189 | 1,391 | 1,337 | 1,390 |
Shareholders' Equity | 9,867 | 10,099 | 8,399 | 8,101 | 6,649 | 6,095 |
Total Liabilities & Equity | 15,275 | 13,985 | 12,304 | 11,729 | 11,203 | 10,317 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,332 | 2,513 | 2,549 | 2,433 | 3,355 | 3,463 |
Net Cash (Debt) | -551.87 | 418.19 | -666.47 | -782.59 | -1,937 | -2,474 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.02 | 0.78 | -1.33 | -1.62 | -4.16 | -5.27 |
Filing Date Shares Outstanding | 542.23 | 542.92 | 499.11 | 499.11 | 463.42 | 467.47 |
Total Common Shares Outstanding | 542.23 | 542.92 | 499.11 | 499.11 | 463.42 | 467.47 |
Working Capital | 3,581 | 4,406 | 2,945 | 2,421 | 1,686 | 1,210 |
Book Value Per Share | 15.95 | 16.14 | 14.45 | 13.44 | 11.46 | 10.07 |
Tangible Book Value | 8,022 | 8,330 | 6,699 | 6,151 | 4,744 | 4,204 |
Tangible Book Value Per Share | 14.79 | 15.34 | 13.42 | 12.32 | 10.24 | 8.99 |
Land | - | 3,392 | 3,528 | 3,528 | 3,558 | 3,558 |
Buildings | - | 1,619 | 1,587 | 1,567 | 1,558 | 1,542 |
Machinery | - | 2,282 | 2,050 | 1,893 | 1,790 | 1,696 |
Construction In Progress | - | 19.41 | 89.55 | 19.08 | 9.74 | 62.51 |
Leasehold Improvements | - | 83.23 | 83.19 | 80.49 | 78.96 | 22.62 |